Literature DB >> 5492617

Essential hypertension and its treatment by the family physician. A study of sixty-one cases.

M H Coigley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5492617      PMCID: PMC2237384     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


× No keyword cloud information.
  20 in total

1.  VARIATION IN ARTERIAL PRESSURE THROUGHOUT THE DAY AND NIGHT.

Authors:  D W RICHARDSON; A J HONOUR; G W FENTON; F H STOTT; G W PICKERING
Journal:  Clin Sci       Date:  1964-06       Impact factor: 6.124

2.  A TRIAL OF LONG-TERM HYPOTENSIVE THERAPY IN CEREBROVASCULAR DISEASE.

Authors:  J MARSHALL
Journal:  Lancet       Date:  1964-01-04       Impact factor: 79.321

3.  Hypertension: treated and untreated; a study of 400 cases.

Authors:  A W LEISHMAN
Journal:  Br Med J       Date:  1959-05-30

4.  Enhanced effectiveness of ganglion-blocking agents in hypertensive patients during administration of a saluretic agent (chlorothiazide).

Authors:  F A TAPIA; H P DUSTAN; R A SCHNECKLOTH; A C CORCORAN; I H PAGE
Journal:  Lancet       Date:  1957-10-26       Impact factor: 79.321

5.  [Pharmacology of reserpin, a new alkaloid from Rauwolfia serpentina Benth].

Authors:  H J BEIN
Journal:  Experientia       Date:  1953-03-15

6.  Clinical use of reserpine (serpasil) in geriatrics.

Authors:  R HARRIS
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

7.  Pharmacology of Rauwolfia alkaloids, including reserpine.

Authors:  A J PLUMMER; A EARL; J A SCHNEIDER; J TRAPOLD; W BARRETT
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

8.  A clinical trial of Rauwolfia serpentina in essential hypertension.

Authors:  R J VAKIL
Journal:  Br Heart J       Date:  1949-10

9.  Clinical experience with bethanidine in treatment of hypertension.

Authors:  J Bath; D Pickering; R Turner
Journal:  Br Med J       Date:  1967-12-02

10.  Clinical usage of Rauwolfia alkaloids, including reserpine (serpasil).

Authors:  R W WILKINS
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.